Immune deviation as a strategy for schistosomiasis vaccines designed to prevent infection and egg-induced immunopathology.
Wynn
T A
TA
The Schistosomiasis Immunology and Pathology Unit, Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
D000818:Animals; D016207:Cytokines / Q000276:immunology; D015769:Granuloma, Respiratory Tract / Q000276:immunology* / Q000469:parasitology / Q000517:prevention & control*; D007378:Interleukins / Q000276:immunology / Q000502:physiology; D008168:Lung / Q000276:immunology; D008198:Lymph Nodes / Q000276:immunology; D051379:Mice; D010063:Ovum / Q000276:immunology; D012550:Schistosoma mansoni / Q000254:growth & development / Q000276:immunology*; D012555:Schistosomiasis mansoni / Q000276:immunology* / Q000517:prevention & control*; D018418:Th2 Cells / Q000276:immunology; D014612:Vaccines / Q000276:immunology*
D016207:Cytokines; D007378:Interleukins; D014612:Vaccines